Rucaparib companion diagnostic - Clovis Oncology/Foundation MedicineAlternative Names: CDxBRCA; FoundationFocus CDxBRCA; Rubraca companion diagnostic
Latest Information Update: 22 Dec 2016
At a glance
- Originator Clovis Oncology; Foundation Medicine
- Class Diagnostic agents
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Registered Ovarian cancer
- Phase III Fallopian tube cancer; Peritoneal cancer